Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Karen Janosko"'
Autor:
Yuji Nagatomo, Dennis M. McNamara, Jeffrey D. Alexis, Leslie T. Cooper, G. William Dec, Daniel F. Pauly, Richard Sheppard, Randall C. Starling, W.H. Wilson Tang, Karen Janosko, Charles McTiernan, Barry London, Karen Hanley-Yanez, John Gorcsan, Hidekazu Tanaka, Mathew Suffoletto, Cynthia Oblak, Annette McNallan, LuAnne Koenig, Paul Mather, Natalie Pierson, Sharon Rubin, Yanique Bell, Alicia Ervin, John Boehmer, Patricia Frey, Jeffrey Alexis, Janice Schrack, Pam LaDuke, Guillermo Torre-Amione, Jeannie Arredondo, Pamela C. Smith, Stephanie Fuoco, Ilan S. Wittstein, Elayne Breton, Vinay Thohan, Deborah Wesley, Diane Cocca-Spofford, David W. Markham, Lynn Fernandez, Colleen Debes, Mark J. Zucker, Laura Adams, Peter Liu, Judith Renton, Jagat Narula, Byron Allen, Elizabeth Westberg
Publikováno v:
Journal of the American College of Cardiology. 69:968-977
Background Among various cardiac autoantibodies (AAbs), those recognizing the β 1 -adrenergic receptor (β 1 AR) demonstrate agonist-like effects and induce myocardial damage that can be reversed by β-blockers and immunoglobulin G3 (IgG3) immunoads
Autor:
Leslie T. Cooper, Randall C. Starling, Kevin E. Kip, Paul J. Mather, Karen Janosko, John Gorcsan, G. William Dec, John P. Boehmer, Dennis M. McNamara
Publikováno v:
Journal of the American College of Cardiology. 58:1112-1118
Objectives We sought to determine clinical and demographic predictors of recovery of left ventricular function for subjects with recent onset cardiomyopathy (ROCM). Background Although ROCM is a frequent reason for consultation and transplantation re
Autor:
Michael L. Sabolinski, Lakshmi Venkitachalam, Jay N. Cohn, Clyde W. Yancy, S. William Tam, Karen Janosko, Elizabeth Ofili, Arthur M. Feldman, Anne L. Taylor, Jalal K. Ghali, Page Tobelmann, Manuel Worcel, Dennis M. McNamara
Publikováno v:
Journal of Cardiac Failure. 15:191-198
Genetic heterogeneity at the endothelial nitric oxide synthase (NOS3) locus influences heart failure outcomes. The prevalence of NOS3 variants differs in black and white cohorts, but the impact of these differences is unknown.Subjects (n = 352) in th
Autor:
Manuel Worcel, S. William Tam, Michael L. Sabolinski, Dennis M. McNamara, Arthur M. Feldman, Karen Janosko, Jay N. Cohn, Page Tobelmann, Anne L. Taylor
Publikováno v:
Journal of the American College of Cardiology. 48(6):1277-1282
OBJECTIVES We sought to evaluate the effect of the aldosterone synthase promoter polymorphism on heart failure outcomes for subjects in the African American Heart Failure Trial (A-HeFT). BACKGROUND Genetic heterogeneity modulates clinical outcomes in
Autor:
Richard Holubkov, Barry London, Arthur M. Feldman, Lisa A. Postava, Karen Janosko, Dennis M. McNamara, Michael A. Mathier, Srinivas Murali, Guy A. MacGowan
Publikováno v:
Journal of the American College of Cardiology. 44:2019-2026
Objectives We evaluated the interaction of angiotensin-converting enzyme (ACE) inhibitor therapy with the effect of the ACE D/I polymorphism on heart failure survival. Background The ACE deletion allele, ACE-D, is associated with increased ACE activi
Autor:
Ravi Ramani, Arthur M. Feldman, Richard Holubkov, Karen Janosko, Michael A. Mathier, Srinivas Murali, Lisa A. Postava, Dennis M. McNamara, Guy A. MacGowan, Barry London
Publikováno v:
Circulation. 107:1598-1602
Background— Significant variation exists within the endothelial nitric oxide synthase (NOS3) gene that may influence cardiovascular risk. The Asp 298 variant of NOS3 has a shorter half-life in endothelial cells. Given the importance of nitric oxide
Autor:
Dennis M. McNamara, Arthur M. Feldman, G. William Dec, Alan Gass, Douglas L. Mann, Richard Holubkov, Randall C. Starling, Paul D. Kessler, Tammy Tokarczyk, Evan Loh, Guillermo Torre-Amione, Karen Janosko
Publikováno v:
Circulation. 103:2254-2259
Background —This prospective placebo-controlled trial was designed to determine whether intravenous immune globulin (IVIG) improves left ventricular ejection fraction (LVEF) in adults with recent onset of idiopathic dilated cardiomyopathy or myocar
Autor:
Dennis M, McNamara, S William, Tam, Michael L, Sabolinski, Page, Tobelmann, Karen, Janosko, Anne L, Taylor, Jay N, Cohn, Arthur M, Feldman, Manuel, Worcel
Publikováno v:
Journal of the American College of Cardiology. 48(6)
We sought to evaluate the effect of the aldosterone synthase promoter polymorphism on heart failure outcomes for subjects in the African American Heart Failure Trial (A-HeFT).Genetic heterogeneity modulates clinical outcomes in subjects with heart fa
Autor:
Srinivas Murali, Flordeliza S. Villaneuva, Warren D. Rosenblum, Karen Janosko, Anthony J. Demetris, Dennis M. McNamara, Arthur M. Feldman, Mary K. Trost
Publikováno v:
Circulation. 95:2476-2478
Background Although an autoimmune pathogenesis has been postulated for dilated cardiomyopathy, immunosuppressive therapy has not been shown to be effective in clinical trials. Immune modulatory therapy with immune globulin is an effective therapy for
Publikováno v:
The American Journal of Cardiology. 79:1264-1266
This retrospective study of 104 New York Heart Association class 1 to 4 heart failure patients undergoing exercise stress testing with gas exchange analysis demonstrated that the ventilatory equivalent for carbon dioxide at anaerobic threshold is use